Access to anti-retroviral drugs, male in New Zealand
New Zealand: Access to anti-retroviral drugs, male was 85.0% in 2024. ▲ Rising
Access to anti-retroviral drugs, male in New Zealand, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
In 2024, access to anti-retroviral drugs, male in New Zealand stood at 85.0%. That is the highest value across all 25 years on record.
That represents a change of up 1.2% on the previous year and up 39.3% over ten years.
Over the whole period, access to anti-retroviral drugs, male in New Zealand peaked at 85.0% in 2024 and was at its lowest, 33.0%, in 2000.
That places New Zealand 34th out of 141 countries with data for 2024, putting it in the top quarter.
The long-run direction has been consistently rising across the 25 years of available data.
Access to anti-retroviral drugs, male in New Zealand, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 33.0% | — |
| 2001 | 36.0% | +9.1% |
| 2002 | 39.0% | +8.3% |
| 2003 | 42.0% | +7.7% |
| 2004 | 44.0% | +4.8% |
| 2005 | 43.0% | -2.3% |
| 2006 | 44.0% | +2.3% |
| 2007 | 45.0% | +2.3% |
| 2008 | 45.0% | +0.0% |
| 2009 | 48.0% | +6.7% |
| 2010 | 51.0% | +6.2% |
| 2011 | 55.0% | +7.8% |
| 2012 | 56.0% | +1.8% |
| 2013 | 58.0% | +3.6% |
| 2014 | 61.0% | +5.2% |
| 2015 | 65.0% | +6.6% |
| 2016 | 69.0% | +6.2% |
| 2017 | 72.0% | +4.3% |
| 2018 | 75.0% | +4.2% |
| 2019 | 75.0% | +0.0% |
| 2020 | 76.0% | +1.3% |
| 2021 | 77.0% | +1.3% |
| 2022 | 78.0% | +1.3% |
| 2023 | 84.0% | +7.7% |
| 2024 | 85.0% | +1.2% |
New Zealand compared with similar countries
- New Zealand's 85.0% is above the median for high income countries, which is 82.0%, 1.0× the median. (39 countries reporting)
- New Zealand's 85.0% is above the median for East Asia & Pacific, which is 62.0%, 1.4× the median. (15 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 41.9% | 33.0% | 48.0% | 10 |
| 2010s | 63.7% | 51.0% | 75.0% | 10 |
| 2020s | 80.0% | 76.0% | 85.0% | 5 |
Countries ranked near New Zealand
More gender data for New Zealand
- Child population (UN estimates and projections) 907.87 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -0.6435 % change on previous year (2030)
- Population 4,499 (2030)
- Working-age population (UN estimates and projections) 4,499 (2030)
- Population (UN estimates and projections), annual growth rate 0.7305 % change on previous year (2030)
- Age population, age 00, female, interpolated 28,751 (2025)
- Age population, age 00, male, interpolated 30,320 (2025)
- Age population, age 01, female, interpolated 29,075 (2025)
- Age population, age 01, male, interpolated 30,663 (2025)
- Age population, age 02, female, interpolated 29,141 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, male in New Zealand?
- Access to anti-retroviral drugs, male in New Zealand was 85.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, male recorded in New Zealand?
- The highest recorded value was 85.0% in 2024.
- What is the lowest access to anti-retroviral drugs, male recorded in New Zealand?
- The lowest recorded value was 33.0% in 2000.
- How does New Zealand rank for access to anti-retroviral drugs, male?
- New Zealand ranks 34th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, male rising or falling in New Zealand?
- Over the last ten years it is up 39.3%. The long-run trend across the full record is rising.
- Where does this New Zealand data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.